722.94
                                            
                                Überblick
                                Nachrichten
                                Preisverlauf
                                    Optionskette
                                Financials
                                    Warum fällt IDXX?
                                Forum
                                Prognose
                                    Aktiensplit
                        
                        Idexx Laboratories Inc Aktie (IDXX) Neueste Nachrichten
IDEXX Laboratories: A Strong Third Quarter With Good Future Prospects (NASDAQ:IDXX) - Seeking Alpha
1,171 Shares in IDEXX Laboratories, Inc. $IDXX Bought by Intellectus Partners LLC - MarketBeat
Does IDEXX Laboratories Inc. fit your quant trading modelDollar Strength & Free High Accuracy Swing Entry Alerts - newser.com
Decoding IDEXX Laboratories Inc (IDXX): A Strategic SWOT Insight - GuruFocus
IDEXX Laboratories Reports Strong Q3 2025 Results - TipRanks
Idexx Laboratories stock reaches 52-week high at $693.00 By Investing.com - Investing.com Nigeria
IDEXX Laboratories Stock Price, Quotes and Forecasts | NASDAQ:IDXX - Benzinga
IDEXX Laboratories Inc. (IDXX) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade
IDEXX Laboratories Jumps 15% on Q3 Earnings Beat - AOL.com
IDEXX Laboratories (IDXX) Reports Strong Q3 2025 Financial Perfo - GuruFocus
Leerink Partners Maintains IDEXX Laboratories Inc(IDXX.US) With Buy Rating, Raises Target Price to $785 - 富途牛牛
Daily Market Wrap: Top Stocks – Amazon, Cipher, and Idexx Laboratories - TheStreet
Why Idexx Laboratories Stock Surged by Almost 15% Today - AOL.com
Why Idexx Laboratories Stock Surged by Almost 15% Today - The Motley Fool
IDEXX Stock on the Rise: What’s Driving the Surge? - timothysykes.com
IDEXX Laboratories Inc. stock outperforms competitors on strong trading day - MarketWatch
IDEXX Laboratories Inc (IDXX) Q3 2025 Earnings Call Highlights: - GuruFocus
IDXX Stock Surges: What this Means - StocksToTrade
IDEXX Laboratories Inc (IDXX) Q3 2025 Earnings Call Highlights: Strong Revenue Growth and ... - Yahoo Finance
IDEXX Laboratories stock price target raised to $775 by Stifel on growth outlook - Investing.com Nigeria
Earnings call transcript: IDEXX Labs Q3 2025 beats expectations, stock surges By Investing.com - Investing.com South Africa
Earnings call transcript: IDEXX Labs Q3 2025 beats expectations, stock surges - Investing.com Canada
Is IDEXX Stock A Smart Buy Now? - timothysykes.com
Stock Markets Diverged As Amazon And IDEXX Stood Out - Finimize
Kenvue, IDEXX Laboratories, Freshpet And Other Big Stocks Moving Higher On Monday - Benzinga
Micron, IDEXX among market cap stock movers on Monday - Investing.com
IDEXX Laboratories’ Stock Soars: Growth or Bubble? - StocksToTrade
Leerink Partners IDEXX Laboratories' Price Target to $785 From $745 - MarketScreener
Triglav Investments D.O.O. Purchases 725 Shares of IDEXX Laboratories, Inc. $IDXX - MarketBeat
Pet Spending Lifts IDEXX Laboratories To Higher Forecasts - Finimize
Research Alert: CFRA Keeps Buy Rating On Shares Of Idexx Laboratories, Inc. - 富途牛牛
Idexx Laboratories Extends Rally Following Upbeat Q3 Earnings, Outlook - Benzinga
Transcript : IDEXX Laboratories, Inc., Q3 2025 Earnings Call, Nov 03, 2025 - MarketScreener
IDEXX Laboratories Inc reports results for the quarter ended September 30Earnings Summary - TradingView
Idexx Laboratories stock reaches 52-week high at $693.00 - Investing.com
IDEXX Laboratories (IDXX): Inside the Pet Diagnostics Leader’s 2025 Breakout 🚀 - ts2.tech
Earnings Summary: Highlights of IDEXX’s Q3 2025 report - AlphaStreet
IDEXX Laboratories, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2025 - MarketScreener
IDEXX Laboratories (IDXX) Surges as Q3 Results Beat Expectations - GuruFocus
Is IDEXX Laboratories, Inc. (NASDAQ:IDXX) Potentially Undervalued? - Yahoo Finance
IDEXX Reports Strong Growth And Lifts 2025 Forecast - Finimize
IDEXX Laboratories stock pops on Q3 beats, raised outlook - MSN
IDEXX raises annual forecasts as pet owners spend more on preventive care - MarketScreener
IDEXX Laboratories stock pops on Q3 beats, raised outlook (IDXX:NASDAQ) - Seeking Alpha
IDEXX Laboratories Q3 2025 Earnings: EPS of $3.40 and Revenue of $1,105 Million Surpass Estimates - GuruFocus
IDEXX (IDXX) Exceeds Revenue Expectations in Q3 - GuruFocus
IDEXX Labs shares jump as pet diagnostics firm beats Q3 estimates - Investing.com
Why retail investors favor IDEXX Laboratories Inc. stock2025 Performance Recap & Advanced Swing Trade Entry Plans - newser.com
IDEXX Laboratories Q3 Earnings, Revenue Rise; Raises 2025 Guidance - MarketScreener
Building trade automation scripts for IDEXX Laboratories Inc.Market Growth Summary & Technical Pattern Based Signals - newser.com
Idexx: Q3 Earnings Snapshot - WKYC
Veterinary diagnostics company beats IDEXX Q3 revenue estimates, hikes FY forecasts - MarketScreener
(IDXX) IDEXX Laboratories Expects 2025 Revenue Range $4.27B to $4.30B, vs. FactSet Est of $4.24B - MarketScreener
(IDXX) IDEXX Laboratories Expects 2025 EPS Range $12.81$13.01, vs. FactSet Est of $12.62 - MarketScreener
Earnings Flash (IDXX) IDEXX Laboratories, Inc. Reports Q3 Revenue $1.11B, vs. FactSet Est of $1.07B - MarketScreener
Earnings Flash (IDXX) IDEXX Laboratories Posts Q3 Comparable EPS $3.22, vs. FactSet Est of $3.12 - MarketScreener
IDEXX Laboratories Announces Third Quarter Results - TradingView
Welch & Forbes LLC Sells 829 Shares of IDEXX Laboratories, Inc. $IDXX - MarketBeat
Crystal Rock Capital Management Sells 600 Shares of IDEXX Laboratories, Inc. $IDXX - MarketBeat
iA Global Asset Management Inc. Acquires 565 Shares of IDEXX Laboratories, Inc. $IDXX - MarketBeat
Quantitative breakdown of IDEXX Laboratories Inc. recent move2025 Trade Ideas & Free AI Powered Buy and Sell Recommendations - newser.com
Mesirow Financial Investment Management Inc. Purchases New Shares in IDEXX Laboratories, Inc. $IDXX - MarketBeat
        In Yahoo öffnen
        |
        In Google öffnen
            |
            In Finviz öffnen
        |
        In MarketWatch öffnen
            |
            Öffnen Sie in EDGAR    
        |
        Offen in Reuters
    
    
                Kapitalisierung:
                 
                  | 
                Volumen (24h):